Home
About
Partnerships
Services
Market Access Analytics and Insight
NICE HTA Strategy and Submission
Health Economics and Outcomes Research (HEOR)
Strategy Development
Reimbursement Strategy and Support
NHS Drug Tariff Submission Support
Private healthcare
Value Proposition Development for MedTech
Primary Care Market Insights
Stakeholder Engagement for Health Technologies
Sustainability and NET Zero for MedTech
Evidence Generation and Management
Dashboard Tools for Market Access
MedTech Sales Team Empowerment
NHS MedTech Business Case Formulation
Blog
Resources
Contact Us
Home
About
Partnerships
Services
Market Access Analytics and Insight
NICE HTA Strategy and Submission
Health Economics and Outcomes Research (HEOR)
Strategy Development
Reimbursement Strategy and Support
NHS Drug Tariff Submission Support
Private healthcare
Value Proposition Development for MedTech
Primary Care Market Insights
Stakeholder Engagement for Health Technologies
Sustainability and NET Zero for MedTech
Evidence Generation and Management
Dashboard Tools for Market Access
MedTech Sales Team Empowerment
NHS MedTech Business Case Formulation
Blog
Resources
Read Our Latest Insights
Welcome to Our Blog
Richard Tuson
Waiting List Rises Again
Richard Tuson
NHS 10 Year Plan Chapter One: The Overview
Richard Tuson
NHS 10 Year Plan Chapter Two: Elective Care, Tariffs and the New Productivity Challenge
Richard Tuson
Life Sciences Sector Plan Chapter Three: NHS Reform and Uptake
Richard Tuson
Hepatitis Awareness Day
Richard Tuson
Sepsis Innovation: Faster Diagnosis, Earlier Treatment, Better Outcomes
Richard Tuson
Sepsis: The Silent Strain on the NHS
Richard Tuson
Sarcoma Awareness Month
Richard Tuson
NHS Drug Tariff Part IX Chapter Three: Reform, Not Revolution
Richard Tuson
Community Diagnostic Centres: Extending Access and Reducing Delays
Richard Tuson
Life Sciences Sector Plan Chapter One: Innovation to Adoption
Richard Tuson
Where the Pressure Sits
Richard Tuson
Gastroparesis Awareness Month
Richard Tuson
June 2025 NHS Diagnostic Waiting Lists
Richard Tuson
NHS Drug Tariff Part IX Chapter One: Re-listing or Removed
Richard Tuson
Life Sciences Sector Plan Chapter Two: Growth and Investment
1
2
Privacy Policy
Cookie Policy
Terms of Use
Contact Us
© Health Analytical Solutions 2025